These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Possible increased anticoagulation effect of warfarin induced by azithromycin. Woldtvedt BR; Cahoon CL; Bradley LA; Miller SJ Ann Pharmacother; 1998 Feb; 32(2):269-70. PubMed ID: 9496419 [No Abstract] [Full Text] [Related]
4. [The effect of Tavan (SP-54) on the coagulation mechanism and fibrinolysis in patients receiving anticoagulant therapy]. Kleynhans P; Retief FP; Bosman AR S Afr Med J; 1969 Dec; 43(49):1504-7. PubMed ID: 4188315 [No Abstract] [Full Text] [Related]
5. [Therapy of chronic viral hepatitis with interferon]. Niederau C; Heintges T Internist (Berl); 1994 Jan; 35(1):70-7; discussion 77-9. PubMed ID: 7511573 [No Abstract] [Full Text] [Related]
6. Why did the response to warfarin change? Porterfield LM RN; 2000 Dec; 63(12):107. PubMed ID: 11151821 [No Abstract] [Full Text] [Related]
7. [Interferon therapy in chronic viral hepatitis?]. Korn A; Müller R Dtsch Med Wochenschr; 1993 Feb; 118(7):240. PubMed ID: 7679965 [No Abstract] [Full Text] [Related]
8. [Interferon in chronic hepatitis]. Planas R; Morillas R Med Clin (Barc); 1991 Nov; 97(18):700-2. PubMed ID: 1722863 [No Abstract] [Full Text] [Related]
9. Interferon-induced thrombocytopenia: is it time for thrombopoietin. Martin TG; Shuman MA Hepatology; 1998 Nov; 28(5):1430-2. PubMed ID: 9794932 [No Abstract] [Full Text] [Related]
10. [A case report on severe coagulations dysfunction induced by interaction of Warfarin and gestgestrinone]. Chen J; Zhang R; Wang W; Li W Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Dec; 42(12):1055. PubMed ID: 25623355 [No Abstract] [Full Text] [Related]
11. Kcentra: a 4-factor prothrombin complex concentrate for reversal of warfarin anticoagulation. Med Lett Drugs Ther; 2013 Jul; 55(1420):53-4. PubMed ID: 23836371 [No Abstract] [Full Text] [Related]
12. [Interferon treatment of chronic viral hepatitis]. Wright HI G E N; 1990; 44(1):71-7. PubMed ID: 1726833 [No Abstract] [Full Text] [Related]
13. [Long-term prognosis after interferon therapy in chronic hepatitis type C]. Inoue O; Yano M Nihon Rinsho; 1994 Jul; 52(7):1828-31. PubMed ID: 7521425 [TBL] [Abstract][Full Text] [Related]
14. [The interferon treatment of chronic hepatitis C. Short- and long-term therapy and the problem of nonresponders]. Perasso A; Testino G Recenti Prog Med; 1993 Feb; 84(2):106-17. PubMed ID: 7681999 [TBL] [Abstract][Full Text] [Related]
15. Reversal of warfarin: case-based practice recommendations. Garcia DA; Crowther MA Circulation; 2012 Jun; 125(23):2944-7. PubMed ID: 22689931 [No Abstract] [Full Text] [Related]
16. Hyperprothrombinemia as a result of a possible warfarin and intravaginal miconazole interaction. Thomas JL; Dunn D; Pelletier A; Franks AS South Med J; 2010 Oct; 103(10):1063-5. PubMed ID: 20802381 [TBL] [Abstract][Full Text] [Related]
18. [Case of C-type chronic hepatitis with manifestation of pituitary insufficiency caused by interferon therapy]. Kato K; Arai K; Arai Y; Enomoto N; Yamada Y; Suzuki I; Tanaka M; Yoshihara H; Yamada Y; Abe H Nihon Naika Gakkai Zasshi; 1996 Oct; 85(10):1757-9. PubMed ID: 8999070 [No Abstract] [Full Text] [Related]
19. Depression from interferon therapy in patients with hepatitis C. Miyaoka H; Otsubo T; Kamijima K; Ishii M; Onuki M; Mitamura K Am J Psychiatry; 1999 Jul; 156(7):1120. PubMed ID: 10401474 [No Abstract] [Full Text] [Related]
20. Interaction between warfarin and mango fruit. Monterrey-Rodríguez J Ann Pharmacother; 2002 May; 36(5):940-1. PubMed ID: 12014354 [No Abstract] [Full Text] [Related] [Next] [New Search]